| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.003 | 1 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.0027 | 1 |